YOD1 Stabilization Promotes Bcl-xL-Dependent Enzalutamide Resistance in Prostate Cancer Models
Researchers identified an m6A-deubiquitinase-Bcl-xL regulatory cascade that promotes resistance to enzalutamide in cellular and animal models of prostate cancer.

